Fauna Bio is an AI-driven biotechnology company focused on drug discovery by studying natural disease resistance in mammals. It leverages an exclusive biobank of genetic data and its in-house Convergence platform to mimic how extreme animal models resist disease, aiming to translate those mechanisms into human therapeutics. The company highlights applications in obesity targets, metabolic health, and space health research, and is based in Emeryville, California. Fauna Bio collaborates with academia and industry partners to accelerate preclinical discovery across multiple disease areas.
No recent news for this company.
No recent deals for this company.